Original document(13 pages)  中文版
    The invention provides the application of honokiol in preparing medicine for treating leukemia. The molecular weight of asid leukemia is 266. 33, the chemical name is 3,5'-diallyl-4,2'-dihydroxybiphenyl, and molecular formula is C18H18O2. The prepared honokiol medicine comprises allowed medicine shaping agent and carrier. The preparation form comprises liquid, particular, tablet, slow-release, infusion, capsule and pill, capsule or injection. The toxicity of honokiol is very low, and the toxicity of anti-tumor medicine in current time is strong, so the prospect of producing anti-leukemia medicine by using honokiol is nice.
Application Number
申请号
200710067213 Application Date
申请日
2007.02.08
Title 名称 Application of honokiol in preparing medicine for treating acute leukemia
Publication Number
公开号
101057836 Publication Date
公开日
2007.10.24
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K31/05;A61K45/06;A61K9/08;A61K9/10;A61K9/14;A61K9/16;A61K9/20;A61P35/02
Applicant(s) Name
申请人
Zhejiang University
Address 地址
Inventor(s) Name 发明人 Hu Xun;Li Ling
Attorney & Agent 代理人 zhangfa gao zhaohang li
More information 更  多  信  息


 Related patents information
Testing mass spectrum model of blood serum protein in carcinoma of large intestine and its creating method
Multidrug resistance reverse agent for tumor
Usage of cytochalasin D in the preparing process of anticancer medicine
Use of alkannin in preparing medicine for treating tumor disease
Usage of honokiol in the preparing process of anti tumor angiopoiesis medicine
Application Hehoupu phenol in preparing antitumour multi medicinal tolerant medicine
Application of Schisandrin-B in preparing medicine for treating tumor
Use of honokiol in preparation of target drug for tumour
Novel bacillus named BARB and its uses
Application of biphenyl cyclo-octadiene lignans for reducing toxic and side effect of antitumor agent
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.